Suramin, an Active Nonhormonal Cytotoxic Drug for Treatment of Prostate Cancer: Compelling Reasons for Testing in Patients With Hormone-Refractory Breast Cancer
- 1 January 1992
- journal article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 84 (1), 3-5
- https://doi.org/10.1093/jnci/84.1.3